PICH, Achille
 Distribuzione geografica
Continente #
EU - Europa 13.824
NA - Nord America 5.566
AS - Asia 1.926
AF - Africa 53
SA - Sud America 42
OC - Oceania 26
Continente sconosciuto - Info sul continente non disponibili 15
Totale 21.452
Nazione #
IT - Italia 9.053
US - Stati Uniti d'America 5.407
CN - Cina 1.136
UA - Ucraina 829
DE - Germania 664
IE - Irlanda 663
FR - Francia 636
SE - Svezia 482
FI - Finlandia 403
KR - Corea 342
GB - Regno Unito 317
PL - Polonia 228
DK - Danimarca 166
JP - Giappone 140
CA - Canada 135
VN - Vietnam 105
AT - Austria 83
IN - India 65
CH - Svizzera 63
ES - Italia 45
SN - Senegal 36
BE - Belgio 35
NL - Olanda 33
TR - Turchia 32
AU - Australia 25
RU - Federazione Russa 24
MX - Messico 20
BR - Brasile 18
IR - Iran 18
EU - Europa 15
RO - Romania 15
HK - Hong Kong 13
GR - Grecia 12
TH - Thailandia 12
CZ - Repubblica Ceca 10
NO - Norvegia 10
SG - Singapore 10
CO - Colombia 9
IL - Israele 8
PT - Portogallo 8
TW - Taiwan 8
AL - Albania 7
CL - Cile 7
EG - Egitto 7
MY - Malesia 7
ID - Indonesia 6
QA - Qatar 6
SK - Slovacchia (Repubblica Slovacca) 6
SM - San Marino 6
BY - Bielorussia 5
HR - Croazia 5
KW - Kuwait 5
PK - Pakistan 5
AR - Argentina 3
BD - Bangladesh 3
BG - Bulgaria 3
EE - Estonia 3
ZA - Sudafrica 3
AE - Emirati Arabi Uniti 2
DZ - Algeria 2
EC - Ecuador 2
LT - Lituania 2
LU - Lussemburgo 2
MD - Moldavia 2
NI - Nicaragua 2
PE - Perù 2
SA - Arabia Saudita 2
SD - Sudan 2
BO - Bolivia 1
BW - Botswana 1
CR - Costa Rica 1
CV - Capo Verde 1
HU - Ungheria 1
IM - Isola di Man 1
MU - Mauritius 1
NZ - Nuova Zelanda 1
PH - Filippine 1
PR - Porto Rico 1
RS - Serbia 1
SI - Slovenia 1
Totale 21.452
Città #
Beijing 843
Dublin 660
Chandler 569
Milan 516
Jacksonville 493
Rome 421
Houston 311
Medford 259
Fairfield 236
Villeurbanne 224
Torino 212
Ann Arbor 208
Princeton 203
Warsaw 194
Wilmington 181
Dearborn 170
Ashburn 169
Nyköping 154
Woodbridge 105
Florence 99
Redwood City 95
Pisa 94
Seattle 89
Verona 88
Los Angeles 85
Cambridge 83
Palermo 82
Toronto 79
Vienna 79
Naples 74
Bologna 70
Dong Ket 70
Turin 70
Boston 58
Napoli 54
Bari 51
Padova 51
Tokyo 45
Catania 44
Fremont 43
Lachine 43
Perugia 43
Boardman 41
Dallas 37
Brescia 35
Falls Church 35
Genova 35
Mountain View 29
Norwalk 29
Shanghai 29
Trieste 29
Guangzhou 27
Genoa 26
Nanjing 23
Pescara 23
Busto Arsizio 19
San Mateo 19
Cagliari 18
Monza 18
Latina 17
Messina 17
New York 17
Rimini 17
Treviso 17
Vicenza 17
Zhengzhou 17
Zurich 17
Bergamo 16
Taranto 16
Brussels 15
Hefei 15
Modena 15
Mumbai 15
Como 14
Parma 14
Pune 14
Hangzhou 13
Helsinki 13
Sassari 13
Venezia 13
Jesi 12
Paris 12
Reggio Emilia 12
San Diego 12
Buffalo 11
Halle 11
Hebei 11
Kunming 11
Livorno 11
Lucca 11
Ravenna 11
Düsseldorf 10
Reggio Calabria 10
Segrate 10
Tianjin 10
Ancona 9
Barcelona 9
Bolzano 9
London 9
Phoenix 9
Totale 8.721
Nome #
Nevo blu cellulare maligno 6.605
L’attività proliferativa nei tumori del capo-collo. 2.026
Significato degli AgNORs in patologia tumorale. 372
Core binding factor acute myeloid leukaemia and c-KIT mutations 367
JAK2V617F activating mutation is associated with the myeloproliferative type of chronic myelomonocytic leukaemia 324
Description of a novel Janus kinase 3 P132A mutation in acute megakaryoblastic leukemia and demonstration of previously reported Janus kinase 3 mutations in normal subjects. 317
Thymic epithelial tumors express vascular endothelial growth factors and their receptors as potential targets of antiangiogenic therapy: A tissue micro array-based multicenter study. 261
Novel CALR somatic mutations in essential thrombocythaemia 225
Myelodysplastic syndrome with del (5q) and JAK2V617F mutation transformed to acute myeloid leukaemia with complex karyotype 212
Essential Differences in Clinical and Bone Marrow Features in BCR/ABL- Positive Thrombocythemia Compared to Thrombocythemia in the BCR/ABL -Negative Myeloproliferative Neoplasms Essential Thrombocythemia and Polycythemia Vera. 189
JAK2V617F mutation and allele burden are associated with distinct clinical and morphological subtypes in patients with essential thrombocythaemia 188
Prognostic relevance of cell proliferation in head and neck tumors 185
WHO Clinical Molecular and Pathological (WHO-CMP) Features of Congenital MPLS505N and the Acquired MPL W515l/K Mutated Essential Thrombocythemia and Myelofibrosis 163
Significato prognostico della attività proliferativa, valutata con conteggio delle regioni organizzatrici del nucleolo (NORs), nella leucemia acuta mieloblastica (LAM) dell’adulto 155
JAK2V617F, CALR, and MPL Mutations and Bone Marrow Histology in Patients with Essential Thrombocythaemia 153
Expression of angiogenesis-related biomarkers in thymic epithelial tumors (TET). 144
Nevo Blu Cellulare Neuro neuroide 131
Chronic myelomonocytic leukaemia with marked thrombocytosis and JAK2V617F mutation transformed into an acute megakaryoblastic leukaemia. 131
The Dilemma of HER2 Double-equivocal Breast Carcinomas: Genomic Profiling and Implications for Treatment 131
KIT and PDGFRA mutations and PDGFRA immunostaining in gastrointestinal stromal tumors 126
EFFECT ON CLINICAL OUTCOME OF BONE MARROW RETICULIN FIBROSIS IN 579 PATIENTS WITH POLYCYTHEMIA VERA AND ESSENTIAL THROMBOCYTHEMIA 122
Utilità della citologia esfoliativa orale per la diagnosi di displasia e carcinoma squamoso orale: confronto tra esame citologico tradizionale ed in fase liquida (“Strato sottile”). 120
Sopravvivenza di soggetti affetti da mieloma in relazione al quadro istologico osteo-midollare 116
Core binding factor acute myeloid leukemia and c-kit mutations 113
Neoplasie papillari superficiali della vescica. Parametri morfologici e biologici correlati con recidive 112
Prognostic value of the rapidity of bone marrow blast cell proliferation in adult acute lymphoblastic leukemia 104
Intrasinusoidal bone marrow infiltration and splenic marginal zone lymphoma: a quantitative study 101
Refractory cytopenia with multilinear dysplasia (RCMD) in patient with Fanconi anaemia 99
Wiskott–Aldrich syndrome protein (WASP) is a tumor suppressor in T cell lymphoma 98
Prognostic value of quantitative analysis of WT1 gene transcripts in adult acute lymphoblastic leukemia 96
Autosomal Dominant Hereditary Essential Thrombocythemia due to a Gain of Function Mutation in the Thrombopoietin (TPO) and JAK2 Gene as the Cause of Congenital Aspirin-Responsive Sticky Platelet Syndrome: Personal Experiences and Review of the Literature 93
Linfomi non-Hodgkin di piccole cellule primitivi della milza: infiltrazione midollare intrasinusoidale come modalità caratteristica di invasione 91
Correlative studies on the presence of oestrogen and prolactin receptors and histology in human breast carcinomas 85
Myelodysplastic syndrome with isolated del (5q) and JAK2V617F mutation transformed into an acute myeloid leukemia. 83
JAK2V617F mutation and allele burden: correlation with morphologic and clinical features and response to therapy in patients with essential thrombocytemia. 83
Bcl-2 expression in male breast carcinoma. 80
LAT (linker for activation of T cells): un utile marcatore per l’identificazione di megacariociti in biopsie osteomidollari. 80
Biologic differences between noninvasive papillary urothelial neoplasms of low malignant potential and low-grade (grade 1) papillary carcinomas of the bladder. 79
Argyrophilic nucleolar organizer region counts and proliferating cell nuclear antigen scores are two reliable indicators of survival in pharyngeal carcinoma 78
Angiogenic activity of hyperplastic and neoplastic lymph nodes 76
Parametri biologici di malignità nei linfomi di piccole cellule CD5 positivi 75
Utilità diagnostica del conteggio degli Organizzatori Nucleolari nella valutazione citologica dei versamenti neoplastici 74
Significato prognostico degli organizzatori nucleolari (AgNORs) nei carcinomi del seno piriforme 73
AgNORs and myeloma prognosis. 73
Gli AgNOR in citologia esfoliativa orale 73
AgNORs, nuclear and nucleolar morphometry in prostate carcinoma 72
JAK2 V617F activating mutation in chronic myelomonocytic leukemia 72
Prognostic value of nucleolar organizer region count in non-invasive thymomas 72
Argyrophilic nucleolar organizer region counts and Ki-67 scores in human renal cell carcinoma. 71
Prognostic relevance of AgNORs in tumor pathology 71
Attività proliferativa di carcinomi di epitelio transizionale della vescica indagata mediante l'analisi degli Organizzatori Nucleolari e la marcatura con l'anticorpo monoclonale anti PCNA (PC10) 71
L'osteodistrofia uremica: correlazione tra dati clinici, radiologici ed istologici in un gruppo di pazienti 69
Argyrophilic nucleolar organizer region counts in malignant melanoma associated with benign intradermal nevus. 68
p53 protein expression in patients with myelodysplasia treated with allogeneic bone marrow transplantation 68
Androgen receptor expression in male breast carcinoma: lack of clinicopathological association. 68
Autopsy and multiple pathology in the elderly 67
Significato delle AgNOR in patologia tumorale. 67
Anatomia Patologica 66
Angiogenesi indotta da tessuto linfatico neoplastico evidenziata con impianto irideo. 66
Studio istologico dei fenomeni riparativi di ulcere distrofiche trattate con Ossigeno ad alte dosi 66
Clinical significance of AgNOR counts in adult acute non-lymphoblastic leukaemia 65
Attività proliferativa dei carcinomi renali e vescicali indagata mediante l'anticorpo monoclonale Ki67 e l'analisi degli organizzatori nucleolari 65
Prognostic value of AgNORs in renal cell carcinoma: results of a prospective study 65
Relationship between AgNORs, MIB-1 and oncogene expression in male breast carcinoma and papillary superficial bladder neoplasm. 64
Acute myelofibrosis and megakaryoblastic leukemia: an immunohistochemical study on bone marrow trephine biopsies 64
Follow-up of 24 cervical condylomata immunocytochemically positive for PV-Ag according to the virus type 64
Alterazioni istologiche del midollo osseo nei pazienti affetti da insufficienza renale cronica sottoposti a dialisi 64
Prognostic value of AgNOR counting. A prospective study in a series of renal cell carcinomas. 63
Intrasinusoidal bone marrow infiltration and splenic marginal zone lymphoma 62
Argyrophilic nucleolar organizer region counts predict survival in thymoma. 62
JAK2V617F MUTATIONAL STATUS IS ASSOCIATED WITH DIFFERENT PHENOTYPES IN ESSENTIAL TROMBOCYTHEMIA 62
Argyrophilic nucleolar organizer region counts and prognosis in multiple myeloma 62
Tyrosine phosphatases regulate resistance to ALK inhibitors in ALK+ anaplastic large cell lymphoma 62
Authors response to Tripodo et al. "Reply to Pich et al.: Intrasinusoidal bone marrow infiltration and splenic marginal zone lymphoma: a quantitative study." 61
A computer network-based system for local storage and nationwide processing of autopsy diagnoses 61
DNA Flow Cytometry, Ki67 and Proliferating Cell Nuclear Antigen (PCNA-PC10) scores in intermediate grade malignant lymphomas 61
Androgen receptors in male breast carcinoma 61
Correlation between argyrophilic nucleolar organizer region counts and labelling index in multiple myeloma 61
[Evolution of acute leukemia in myelodysplastic syndromes: prognostic histopathological factors in a series of bone marrow biopsies] 61
Argyrophilic nucleolar organizer region counts in multiple myeloma: a histopathological study on bone marrow trephine biopsies 61
Nucleolar organiser regions in bone marrow biopsies of patients with acute myelogeneous leukaemia 60
The diagnostic value of histological findings in cervical condylomata immunohistochemically positive for papilloma virus (HPV) 60
Argyrophilic nucleolar organiser region counts and prognosis in pharyngeal carcinoma. 60
Experimental investigation on histocompatibility of bovine collagen in rat tongue 60
JAK2V617F, CALR and MPL mutations and bone marrow histology in patients with essential thrombocythemia. 60
Estensione della coilocitosi e positività immunoistochimica per il virus del papilloma in biopsie di condilomi della cervice uterina 59
Attività proliferativa di linfomi maligni di gruppo intermedio valutata con l'analisi del DNA e la marcatura con gli anticorpi monoclonali Ki67 e anti PCNA (PC10) 59
Analysis of nucleolar organizer regions is predictive of complete remission in patients with acute myeloid leukemia 58
Proliferative activity is a significant prognostic factor in male breast carcinoma. 58
Discrasie delle plasmacellule e gammopatie 57
In male breast carcinoma DNA flowcytometric ploidy correlates with proliferative activity and prognosis 57
Bone marrow histopathology and prognosis in malignant lymphomas. 57
Argyrophilic nucleolar organizer regions (AgNORs) counts, proliferating cell nuclear antigen (PCNA) scores and DNA flow cytometry of bladder urotheliomas in routinely treated biopsies 57
Valutazione degli AgNORs e di MIB-1 quali fattori prognostici dei carcinomi del seno piriforme sottoposti a radioterapia 56
AgNOR proliferation index and development of hepatocellular carcinoma in cirrhosis 56
Cell proliferation, bcl-2, c-myc, p53 and apoptosis as indicators of different aggressiveness in small lymphocytic lymphoma (SLL) 56
Valutazione dell'attività Timidina-chinasica nei liquidi di versamenti come controllo dell'accuratezza diagnostica citologica 56
Therapy and survival in male breast carcinoma: A retrospective analysis of 50 cases. 55
AgNORs in melanomi associati a nevi intradermici 55
JAK2V617F mutation and allele burden in patients with essential thrombocythemia 55
Totale 18.118
Categoria #
all - tutte 41.959
article - articoli 0
book - libri 0
conference - conferenze 21.823
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 63.782


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019820 0 0 0 0 0 0 0 0 0 181 422 217
2019/20203.411 190 212 375 261 404 402 345 208 365 179 266 204
2020/20213.110 380 156 284 171 240 178 295 141 398 292 231 344
2021/20222.353 174 141 140 149 131 114 192 156 133 139 335 549
2022/20233.585 360 194 140 285 292 753 357 275 345 130 220 234
2023/20241.702 279 234 103 146 112 147 275 162 52 192 0 0
Totale 22.027